Streetbeat News

Stock Prices

BYDDY

TM

BYD Co Ltd has launched its third electric vehicle model, the BYD Seal sedan, in Japan, directly competing with Toyota's RAV4 PHEV. The Seal will be available in two variants, with deliveries starting in July and August. BYD is offering an introductory discount for the first 1,000 customers.

Portfolio Pulse from Anan Ashraf

June 25, 2024 | 12:18 pm

HUMA

Humacyte, Inc. (NASDAQ:HUMA) presented positive preclinical data for its BioVascular Pancreas (BVP) program, a potential treatment for type 1 diabetes. The BVP product candidate showed promising results in restoring normal blood glucose levels in diabetic mice and demonstrated islet survival and continued insulin production in non-human primate models.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 12:14 pm

BALL

CHRW

CRDO

MQ

NET

Top Wall Street analysts have upgraded their ratings for several companies, including Marqeta, C.H. Robinson Worldwide, Ball Corporation, Cloudflare, and Credo Technology Group. These upgrades reflect positive outlooks and increased price targets for the respective stocks.

Portfolio Pulse from Avi Kapoor

June 25, 2024 | 12:13 pm

MNPR

Monopar Therapeutics Inc. (NASDAQ:MNPR) announced that its abstract on the evaluation of an anti-uPAR antibody as a radiopharmaceutical for imaging and treatment of solid tumors has been accepted as a 'Top-Rated Oral Presentation' at the EANM 2024 Annual Congress.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 12:12 pm

BIVI

BioVie Inc. presented the protocol design for its upcoming SUNRISE-PD Phase 2 trial of bezisterim (NE3107) in early Parkinson's disease patients at the ATMRD 2024 Congress. The trial will evaluate the drug's effect on motor and non-motor symptoms in approximately 60 patients. Data from an earlier Phase 2a trial were also highlighted.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 12:11 pm

ALLR

Allarity Therapeutics announced that multiple patients in its Phase 2 Stenoparib trial have exceeded 30 weeks on treatment, indicating positive progress in the trial.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 12:10 pm

LFMD

LifeMD, Inc. (NASDAQ:LFMD) has launched private health insurance acceptance for its virtual primary care services, including weight management. Initially available in select states, the company plans to expand coverage nationwide and begin accepting Medicare by early 2025.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 12:10 pm

ALLR

Allarity Therapeutics (NASDAQ: ALLR) announced that multiple patients in its Phase 2 clinical trial of stenoparib for advanced recurrent ovarian cancer have been on treatment for more than 30 weeks, indicating extended clinical benefit.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 12:09 pm

HESM

Hess Midstream has announced a definitive agreement for the repurchase of approximately $100 million of Class B units by its subsidiary, Hess Midstream Operations LP.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 12:08 pm

DJT

Trump Media & Technology Group Corp (NASDAQ:DJT) saw a significant surge of over 21% on Monday, recovering from a decline following Trump's legal issues. The stock closed at $33.52, up from $27 on Friday. The company expects to generate over $69.4 million from exercised warrants, but concerns about stock dilution remain. Short sellers have faced substantial losses, totaling $178 million year-to-date. Trump is also set to speak at the Bitcoin 2024 convention, highlighting his pro-crypto stance.

Portfolio Pulse from Anusuya Lahiri

June 25, 2024 | 12:08 pm